Sign up to save your podcasts
Or
Share S1E25 Keythera Submitted First IND for KF-0210
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S1E25 Keythera Submitted First IND for KF-0210
近日，国家药品监督管理局药品审评中心公示凯复（苏州）生物提交KF-0210临床申请，根据此前报道，KF-0210为凯复独立研发的EP4拮抗剂
View all episodes
By Pharmews
5
11 ratings
近日，国家药品监督管理局药品审评中心公示凯复（苏州）生物提交KF-0210临床申请，根据此前报道，KF-0210为凯复独立研发的EP4拮抗剂